目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary €“ Chart on Market Overview
Exhibit 02: Executive Summary €“ Data Table on Market Overview
Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary €“ Chart on Incremental Growth
Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global fungal keratitis treatment market 2017 - 2021
Exhibit 18: Historic Market Size €“ Data Table on global fungal keratitis treatment market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size €“ Route of Administration Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size €“ Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Injection - Market size and forecast 2022-2027
Exhibit 38: Chart on Injection - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Injection - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Injection - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Injection - Year-over-year growth 2022-2027 (%)
6.5 Topical - Market size and forecast 2022-2027
Exhibit 42: Chart on Topical - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Topical - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Route of Administration
Exhibit 46: Market opportunity by Route of Administration ($ million)
Exhibit 47: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Drug stores - Market size and forecast 2022-2027
Exhibit 56: Chart on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Drug stores - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Alvogen Iceland ehf
Exhibit 115: Alvogen Iceland ehf - Overview
Exhibit 116: Alvogen Iceland ehf - Product / Service
Exhibit 117: Alvogen Iceland ehf - Key offerings
12.4 Aravind Eye Care System
Exhibit 118: Aravind Eye Care System - Overview
Exhibit 119: Aravind Eye Care System - Product / Service
Exhibit 120: Aravind Eye Care System - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 121: Astellas Pharma Inc. - Overview
Exhibit 122: Astellas Pharma Inc. - Product / Service
Exhibit 123: Astellas Pharma Inc. - Key news
Exhibit 124: Astellas Pharma Inc. - Key offerings
12.6 Bayer AG
Exhibit 125: Bayer AG - Overview
Exhibit 126: Bayer AG - Business segments
Exhibit 127: Bayer AG - Key news
Exhibit 128: Bayer AG - Key offerings
Exhibit 129: Bayer AG - Segment focus
12.7 Cipla Ltd.
Exhibit 130: Cipla Ltd. - Overview
Exhibit 131: Cipla Ltd. - Business segments
Exhibit 132: Cipla Ltd. - Key news
Exhibit 133: Cipla Ltd. - Key offerings
Exhibit 134: Cipla Ltd. - Segment focus
12.8 Gilead Sciences Inc.
Exhibit 135: Gilead Sciences Inc. - Overview
Exhibit 136: Gilead Sciences Inc. - Product / Service
Exhibit 137: Gilead Sciences Inc. - Key news
Exhibit 138: Gilead Sciences Inc. - Key offerings
12.9 Glenmark Pharmaceuticals Ltd.
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
12.10 ISKON REMEDIES and GMT
Exhibit 142: ISKON REMEDIES and GMT - Overview
Exhibit 143: ISKON REMEDIES and GMT - Product / Service
Exhibit 144: ISKON REMEDIES and GMT - Key offerings
12.11 Merck and Co. Inc.
Exhibit 145: Merck and Co. Inc. - Overview
Exhibit 146: Merck and Co. Inc. - Business segments
Exhibit 147: Merck and Co. Inc. - Key news
Exhibit 148: Merck and Co. Inc. - Key offerings
Exhibit 149: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 150: Novartis AG - Overview
Exhibit 151: Novartis AG - Business segments
Exhibit 152: Novartis AG - Key offerings
Exhibit 153: Novartis AG - Segment focus
12.13 Novo Holdings AS
Exhibit 154: Novo Holdings AS - Overview
Exhibit 155: Novo Holdings AS - Product / Service
Exhibit 156: Novo Holdings AS - Key news
Exhibit 157: Novo Holdings AS - Key offerings
12.14 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product / Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.15 Santen Pharmaceutical Co. Ltd.
Exhibit 162: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 163: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 164: Santen Pharmaceutical Co. Ltd. - Key offerings
12.16 Viatris Inc.
Exhibit 165: Viatris Inc. - Overview
Exhibit 166: Viatris Inc. - Business segments
Exhibit 167: Viatris Inc. - Key news
Exhibit 168: Viatris Inc. - Key offerings
Exhibit 169: Viatris Inc. - Segment focus
12.17 Wellona Pharma
Exhibit 170: Wellona Pharma - Overview
Exhibit 171: Wellona Pharma - Product / Service
Exhibit 172: Wellona Pharma - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size €“ Data Table on global fungal keratitis treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size €“ Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size €“ Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Injection - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Injection - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Injection - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Injection - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Topical - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Route of Administration ($ million)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Distribution Channel ($ million)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Alvogen Iceland ehf - Overview
Exhibits116: Alvogen Iceland ehf - Product / Service
Exhibits117: Alvogen Iceland ehf - Key offerings
Exhibits118: Aravind Eye Care System - Overview
Exhibits119: Aravind Eye Care System - Product / Service
Exhibits120: Aravind Eye Care System - Key offerings
Exhibits121: Astellas Pharma Inc. - Overview
Exhibits122: Astellas Pharma Inc. - Product / Service
Exhibits123: Astellas Pharma Inc. - Key news
Exhibits124: Astellas Pharma Inc. - Key offerings
Exhibits125: Bayer AG - Overview
Exhibits126: Bayer AG - Business segments
Exhibits127: Bayer AG - Key news
Exhibits128: Bayer AG - Key offerings
Exhibits129: Bayer AG - Segment focus
Exhibits130: Cipla Ltd. - Overview
Exhibits131: Cipla Ltd. - Business segments
Exhibits132: Cipla Ltd. - Key news
Exhibits133: Cipla Ltd. - Key offerings
Exhibits134: Cipla Ltd. - Segment focus
Exhibits135: Gilead Sciences Inc. - Overview
Exhibits136: Gilead Sciences Inc. - Product / Service
Exhibits137: Gilead Sciences Inc. - Key news
Exhibits138: Gilead Sciences Inc. - Key offerings
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: ISKON REMEDIES and GMT - Overview
Exhibits143: ISKON REMEDIES and GMT - Product / Service
Exhibits144: ISKON REMEDIES and GMT - Key offerings
Exhibits145: Merck and Co. Inc. - Overview
Exhibits146: Merck and Co. Inc. - Business segments
Exhibits147: Merck and Co. Inc. - Key news
Exhibits148: Merck and Co. Inc. - Key offerings
Exhibits149: Merck and Co. Inc. - Segment focus
Exhibits150: Novartis AG - Overview
Exhibits151: Novartis AG - Business segments
Exhibits152: Novartis AG - Key offerings
Exhibits153: Novartis AG - Segment focus
Exhibits154: Novo Holdings AS - Overview
Exhibits155: Novo Holdings AS - Product / Service
Exhibits156: Novo Holdings AS - Key news
Exhibits157: Novo Holdings AS - Key offerings
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits163: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits164: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits165: Viatris Inc. - Overview
Exhibits166: Viatris Inc. - Business segments
Exhibits167: Viatris Inc. - Key news
Exhibits168: Viatris Inc. - Key offerings
Exhibits169: Viatris Inc. - Segment focus
Exhibits170: Wellona Pharma - Overview
Exhibits171: Wellona Pharma - Product / Service
Exhibits172: Wellona Pharma - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations